Mounjaro Tirzepatide Injection Mounjaro 5.0 mg
Mounjaro
Tirzepatide Injection
Product information for those who want to understand Mounjaro in an easy-to-read format. Suitable for use as supplemental information before consulting a doctor or specialist.
What is Mounjaro?
Mounjaro is the trade name for Tirzepatide, a once-weekly subcutaneous injection medication. It acts on GIP and GLP-1 receptors and is used according to a doctor's treatment plan to help support blood sugar control in conjunction with diet and exercise.
Key Features of Mounjaro:
1. Dual Action:
Tirzepatide acts on both GIP and GLP-1 receptor agonists, supporting the body's natural blood sugar regulation mechanisms.
2. Once-Weekly Injection:
Generally administered as a subcutaneous injection once a week at an appropriate time and day. Users should receive instructions on how to use it from a doctor, pharmacist, or specialist before actual use.
3. Multiple Dosages Available:
Several dosages are available, such as 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Dosage adjustments can be made to the starting dose, increase the dose, or change the dose. Should only be used under the discretion of a physician.
4. Helps plan ongoing care.
Suitable for those who want to maintain their health under medical supervision, as the use of this group of medications requires periodic assessment of symptoms, side effects, and suitability.
Key Ingredients
Active ingredient: Tirzepatide
Drug class: GIP and GLP-1 receptor agonist
Form: Subcutaneous injection
Frequency of use: Generally once a week as directed by a physician.
Dose: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
Who is it suitable for?
Individuals deemed suitable for Tirzepatide by a physician.
Individuals who want to manage blood sugar levels under a physician's treatment plan.
Individuals who can continuously monitor symptoms and side effects.
Individuals who understand the correct injection method, storage, and precautions.
Important Precautions
Do not self-medicate without medical advice, especially if you have a history of MTC thyroid cancer, MEN2 syndrome, are pregnant, planning to become pregnant, breastfeeding, or have any significant underlying medical conditions. Always inform your doctor before use.
Basic Instructions for Use
1. Pre-Use Check:
Check the medication name, dosage, expiration date, and condition before each injection.
2. Subcutaneous Injection:
Suitable locations include the abdomen, thigh, or back of the upper arm, as advised by a healthcare professional.
3. Weekly Injection:
It is recommended to inject on the same day each week for easier monitoring of medication use.
4. Alternate Injection Sites:
Avoid injecting in the same site repeatedly to reduce the risk of skin irritation.
Storage Information:
Refrigerate:
Store at 2–8°C and keep in the original container to protect from light.
Outside Refrigeration:
Can be stored at temperatures not exceeding 30°C for up to 21 days, as per product information.
Do Not Freeze:
If the medication is frozen or appears abnormal, do not use it.
Potential Side Effects:
Potential side effects in some individuals include nausea, diarrhea, vomiting, constipation, abdominal pain, loss of appetite, or irritation at the injection site. If symptoms are severe or do not improve, consult a doctor immediately.
If you experience any unusual symptoms such as severe abdominal pain, excessive vomiting, dizziness, difficulty breathing, rash, swelling, or an allergic reaction, stop using the medication and seek medical attention immediately.